MedTrace Logo

Integrative Analysis of Large-cell Lung Cancer

NCT02917369 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2016-09-28

No results posted yet for this study

Summary

Integrative analysis of LCLC

Conditions

Interventions

OTHER

Normal lung tissue

The investigators will extract total protein, DNA and RNA from LCLC patients.

Sponsors & Collaborators

  • Shanghai Pulmonary Hospital, Shanghai, China

    collaborator OTHER

  • Shanghai 10th People's Hospital

    lead OTHER

Principal Investigators

  • Da Fu, PhD · Shanghai 10th People's Hospital

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02917369 on ClinicalTrials.gov